open access

Vol 60, No 1 (2009)
Review article
Published online: 2008-12-19
Submitted: 2013-02-15
Get Citation

Relationship between toxic effects of potassium bromate and endocrine glands

Magdalena Stasiak, Andrzej Lewiński, Małgorzata Karbownik-Lewińska
Endokrynologia Polska 2009;60(1):40-50.

open access

Vol 60, No 1 (2009)
Review article
Published online: 2008-12-19
Submitted: 2013-02-15

Abstract

Potassium bromate (KBrO3) is a compound belonging to Group 2B of carcinogens (a possible human carcinogen). This agent was used as a food additive in flour treatment, as a component of cold-wave hair lotions, and is still used in barley processing. Additionally, KBrO3 is formed as an oxyhalide by-product during water ozonation.
KBrO3 induces oxidative stress and may contribute to neoplasia in endocrine glands. It has been demonstrated that KBrO3 triggers thyroid follicular cell tumors in rats. It has been revealed in our in vivo and in vitro studies that KBrO3 significantly increases lipid peroxidation in rat and porcine thyroid. KBrO3 also induces mesotheliomas which may secrete hormones or similar substances, such as parathyroid hormone related protein, phosphatonins or melanocyte stimulating hormone.
In our experimental studies we demonstrated that antioxidants, such as pineal hormone - melatonin, indole-3-propionic acid (IPA) (a compound chemically and physically similar to melatonin) and antythyroid drug - propylthiouracil (PTU), produce distinct protective effects against lipid peroxidation due to KBrO3 in the thyroid in vivo.
KBrO3 is a prooxidant which may induce neoplasia in endocrine glands and cause hormonal disturbances, however its damaging effects may be neutralized by hormones, mainly melatonin.

Abstract

Potassium bromate (KBrO3) is a compound belonging to Group 2B of carcinogens (a possible human carcinogen). This agent was used as a food additive in flour treatment, as a component of cold-wave hair lotions, and is still used in barley processing. Additionally, KBrO3 is formed as an oxyhalide by-product during water ozonation.
KBrO3 induces oxidative stress and may contribute to neoplasia in endocrine glands. It has been demonstrated that KBrO3 triggers thyroid follicular cell tumors in rats. It has been revealed in our in vivo and in vitro studies that KBrO3 significantly increases lipid peroxidation in rat and porcine thyroid. KBrO3 also induces mesotheliomas which may secrete hormones or similar substances, such as parathyroid hormone related protein, phosphatonins or melanocyte stimulating hormone.
In our experimental studies we demonstrated that antioxidants, such as pineal hormone - melatonin, indole-3-propionic acid (IPA) (a compound chemically and physically similar to melatonin) and antythyroid drug - propylthiouracil (PTU), produce distinct protective effects against lipid peroxidation due to KBrO3 in the thyroid in vivo.
KBrO3 is a prooxidant which may induce neoplasia in endocrine glands and cause hormonal disturbances, however its damaging effects may be neutralized by hormones, mainly melatonin.
Get Citation

Keywords

potassium bromate; oxidative stress; melatonin; endocrine glands; thyroid gland; hormones

About this article
Title

Relationship between toxic effects of potassium bromate and endocrine glands

Journal

Endokrynologia Polska

Issue

Vol 60, No 1 (2009)

Pages

40-50

Published online

2008-12-19

Bibliographic record

Endokrynologia Polska 2009;60(1):40-50.

Keywords

potassium bromate
oxidative stress
melatonin
endocrine glands
thyroid gland
hormones

Authors

Magdalena Stasiak
Andrzej Lewiński
Małgorzata Karbownik-Lewińska

Important: This website uses cookies.tanya dokter More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl